Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.57 +0.04 (+2.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Goodwill & Intangibles (2025 - 2026)

Updated

Transcode Therapeutics (RNAZ) reported Goodwill & Intangibles of $140.04 million for Q2 2026, unchanged from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Goodwill & Intangibles (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Transcode Therapeutics 1.59 Mn 1.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.04 Mn
Mar 31, 2026 140.04 Mn
Dec 31, 2025 140.04 Mn
API Access

Transcode Therapeutics Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=RNAZ&period=max&api_key=YOUR_API_KEY